|
|
cell adhesion
|
GO:0007155 |
329 |
0.966
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.948
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.948
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.947
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.945
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.942
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.926
|
Human |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.915
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.913
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.910
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.906
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.900
|
Human |
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.894
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.881
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.876
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.863
|
Human |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.863
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.859
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.854
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.846
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.839
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.835
|
Human |
|
|
positive regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030511 |
12 |
0.832
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.824
|
Human |
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.810
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.806
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.790
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.783
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.781
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.775
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.773
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.763
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.762
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.758
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.739
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.737
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.737
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.730
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.726
|
Human |
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.706
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.704
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.689
|
Human |
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.668
|
Human |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.668
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.662
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.655
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.650
|
Human |
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.648
|
Fly |
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.634
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.630
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.629
|
Human |
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.622
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.622
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.620
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.617
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.606
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.605
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.604
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.594
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.591
|
Mouse |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.589
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.573
|
Human |
|
|
regionalization
|
GO:0003002 |
337 |
0.563
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.562
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.551
|
Human |
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.549
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.545
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.544
|
Human |
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.541
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.540
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.527
|
Human |
|
|
urogenital system development
|
GO:0001655 |
261 |
0.522
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.521
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.514
|
Human |
|
|
mononuclear cell migration
|
GO:0071674 |
8 |
0.513
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.511
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.511
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.509
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.503
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.501
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.498
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.497
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.497
|
Human |
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.494
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.481
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.480
|
Human |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.477
|
Human |
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.474
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.474
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.469
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.467
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.466
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.465
|
Human |
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.456
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.447
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.446
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.441
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.435
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.427
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.424
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.422
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.421
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.419
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.419
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.407
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.404
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.400
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.399
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.389
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.388
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.384
|
|
|
|
wound healing involved in inflammatory response
|
GO:0002246 |
4 |
0.380
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.379
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.378
|
|
|
|
inflammatory response to wounding
|
GO:0090594 |
4 |
0.376
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.371
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.370
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.368
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.363
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.359
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.357
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.353
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.349
|
Human |
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.345
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.345
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.343
|
|
|
|
negative regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045736 |
9 |
0.337
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.336
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.334
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.334
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.333
|
Human |
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.332
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.328
|
Human |
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.327
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.322
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.320
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.319
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.319
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.317
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.317
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.317
|
Human |
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.315
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.315
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.315
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.313
|
Human |
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.312
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.311
|
Mouse |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.307
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.307
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.307
|
Human |
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.305
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
14 |
0.299
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.297
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.290
|
Human |
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.288
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.287
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.284
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.283
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.281
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.280
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.279
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.275
|
Human |
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.273
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.273
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.265
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.264
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.262
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.262
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.260
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.259
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.257
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.254
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.252
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.250
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.249
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.249
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.248
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.247
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.247
|
Human |
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.246
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.243
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.242
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.242
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.241
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.241
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.240
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.240
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.239
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.238
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.236
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.235
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.235
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.234
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.233
|
Human |
|
|
lung development
|
GO:0030324 |
164 |
0.232
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.231
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.229
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.228
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.228
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.228
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.227
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.225
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.223
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.220
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.220
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.220
|
Mouse |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.220
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.220
|
Human |
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.219
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.218
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.217
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.214
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.212
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.212
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.212
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.211
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.211
|
Human |
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.209
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.209
|
Human |
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.209
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.207
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.206
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.205
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.200
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.199
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.198
|
Mouse |
|
|
appendage development
|
GO:0048736 |
166 |
0.197
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.197
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.195
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.195
|
Human |
|
|
positive regulation of macrophage chemotaxis
|
GO:0010759 |
5 |
0.194
|
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.193
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.191
|
|
|
|
positive regulation of sphingolipid biosynthetic process
|
GO:0090154 |
1 |
0.190
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.190
|
Human |
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.189
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.187
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.187
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.186
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.185
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.185
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.185
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.184
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.184
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.183
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.181
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.180
|
Human |
|
|
cation transport
|
GO:0006812 |
399 |
0.180
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.178
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.177
|
Human |
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.177
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.177
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.176
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.175
|
Human |
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.174
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.174
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.173
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.172
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.172
|
|
|
|
positive regulation of smad protein import into nucleus
|
GO:0060391 |
2 |
0.171
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.170
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.169
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.169
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.169
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.169
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.167
|
Human |
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.167
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.162
|
Human |
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.160
|
Human |
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.160
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.160
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.158
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.158
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.156
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.153
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.152
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.149
|
Human |
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.149
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.148
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.146
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.146
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.146
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.145
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.145
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.144
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.143
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.143
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.142
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.140
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.139
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.139
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.138
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.137
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.137
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.136
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.135
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.135
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.135
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.134
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.134
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.134
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.133
|
Human |
|
|
epiboly
|
GO:0090504 |
8 |
0.132
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.132
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.131
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.131
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.130
|
|
|
|
g0 to g1 transition
|
GO:0045023 |
3 |
0.130
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.129
|
Human |
|
|
hindbrain development
|
GO:0030902 |
128 |
0.128
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.128
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.127
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.127
|
Mouse |
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.127
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.127
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.127
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.125
|
Human |
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.124
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.124
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.124
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.123
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.122
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.122
|
Human |
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.121
|
|
|
|
negative regulation of cell cycle arrest
|
GO:0071157 |
1 |
0.120
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.120
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.120
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.118
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.117
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.117
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.117
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.116
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.116
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.116
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.114
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.114
|
Human |
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.113
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.112
|
|
|
|
regulation of synaptic transmission glutamatergic
|
GO:0051966 |
19 |
0.110
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.110
|
|
|
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
1 |
0.110
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.109
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.108
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.108
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.107
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.106
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.106
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.106
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.104
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.104
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.104
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.103
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.103
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.103
|
Human |
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.103
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.103
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.102
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.102
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.102
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.102
|
|
|
|
negative regulation of dna damage response signal transduction by p53 class mediator
|
GO:0043518 |
5 |
0.100
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.100
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.099
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.099
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.099
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.098
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.097
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.097
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.097
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
20 |
0.097
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.097
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.097
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.097
|
Human |
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.096
|
Human |
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.096
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.096
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.095
|
Human |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.095
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.095
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.095
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.095
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.094
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.093
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.093
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.093
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.092
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.091
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.091
|
Human |
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.090
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.090
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.090
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.090
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.089
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.089
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.089
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.088
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.088
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.087
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.087
|
Fly |
|
|
response to alcohol
|
GO:0097305 |
48 |
0.087
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.086
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.085
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.085
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.085
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.084
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.084
|
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.083
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.082
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.081
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.080
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.080
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.080
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.080
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.080
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.080
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.080
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.079
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.079
|
Human |
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.079
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.078
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.077
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.077
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.077
|
Human |
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.076
|
Human |
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.075
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.075
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.074
|
Human |
|
|
camera type eye development
|
GO:0043010 |
266 |
0.074
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.074
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.073
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.072
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.072
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.071
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.071
|
Human |
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.071
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.071
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.071
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.070
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.070
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.070
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.070
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.070
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.069
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
20 |
0.069
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.069
|
Human |
|
|
cell aggregation
|
GO:0098743 |
18 |
0.068
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.068
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.068
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.068
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.067
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.067
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.066
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.066
|
Human |
|
|
nerve development
|
GO:0021675 |
67 |
0.066
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.065
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.065
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.065
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.065
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.065
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.065
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.065
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.064
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.064
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.064
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.064
|
|
|
|
positive regulation of cartilage development
|
GO:0061036 |
18 |
0.064
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.064
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.064
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.063
|
Human |
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.063
|
|
|
|
negative regulation of organ growth
|
GO:0046621 |
17 |
0.063
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.063
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.063
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.063
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.062
|
Human |
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.062
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.062
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.062
|
Human |